{
    "Trade/Device Name(s)": [
        "Remel Xpect Flu A&B",
        "Xpect Flu A&B Test",
        "Xpect\u00ae Flu A&B"
    ],
    "Submitter Information": "Thermo Fisher Scientific Remel Products",
    "510(k) Number": "K092423",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031565"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "January 4, 2010",
    "Summary Letter Received Date": "August 7, 2009",
    "Submission Date": "August 6, 2009",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral antigens (nucleoprotein)",
        "Influenza B viral antigens (nucleoprotein)"
    ],
    "Specimen Type(s)": [
        "Nasal wash",
        "Nasal swab",
        "Throat swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Immunochromatography",
        "Membrane assay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Remel Xpect Flu A&B immunochromatographic rapid test for direct detection of influenza A and B viral antigens from respiratory specimens.",
    "Indications for Use Summary": "Rapid, qualitative detection and differentiation of influenza A and influenza B viral antigens (nucleoprotein) from nasal wash, nasal swab, and throat swab specimens from symptomatic patients; aids in rapid diagnosis of influenza A and B infections with negative results requiring confirmation by cell culture.",
    "fda_folder": "Microbiology"
}